概括
我们开发了CoxPH-SuSiE,这是一个新的贝叶斯变量选择回归方法,用于时间到事件数据,在基因精细映射中表现出色,具有高度相关的协变量和大型数据集. 这种方法成功地确定了潜在的因果性喘风险变异.
科学领域:
- 遗传学 遗传学 是一个
- 统计遗传学 统计遗传学
- 生物信息学是一种生物信息学.
背景情况:
- 基因精细映射需要强大的统计方法来识别因果变异.
- 现有的贝叶斯变量选择回归 (BVSR) 方法面临着在遗传研究中常见的高协同变量相关性和大样本大小的挑战.
研究的目的:
- 引入CoxPH-SuSiE,这是对贝叶斯变量选择回归 (BVSR) 单一效应总和 (SuSiE) 方法的扩展,适用于时间到事件 (TTE) 结果.
- 为了应对高协同变量相关性和大数据集在遗传精细映射中的挑战.
主要方法:
- 将单一效应总和 (SuSiE) 方法扩展到Cox比例危险 (CoxPH) 模型,创建了CoxPH-SuSiE.
- 将CoxPH-SuSiE应用于模拟的基因精细映射数据集,以评估与现有的BVSR方法相比的性能.
- 利用CoxPH-SuSiE对英国生物库数据中的喘风险位点进行精细映射.
主要成果:
- 考克斯PH-SuSiE在模拟精细映射数据中的TTE结果方面表现优于现有的BVSR方法.
- 喘位置的精细映射在8个风险位置中确定了14个单核酸多态 (SNP).
- 其中六种SNP显示有强有力的证据 (后续包括概率>50%) 是因果的,包括已知的致病变体和GATA3.3的调节元素.
结论:
- 考克斯PH-SuSiE是贝叶斯变量选择回归在时间到事件数据中的有效方法,特别是用于基因精细映射.
- 该方法成功地确定了喘风险的假定因果变异,突出了其在现实世界遗传研究中的实用性.
- 这些发现提供了关于喘遗传结构的见解,以及特定变异在疾病调节中的作用.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
378
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
378
Assumptions of Survival Analysis
104
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
104
Introduction To Survival Analysis
189
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
189
Comparing the Survival Analysis of Two or More Groups
158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158
The Mantel-Cox Log-Rank Test
326
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
326
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
421
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
421


